Note: This section contains information in English only.
Wed, 07 May 2025 12:30:05 GMT
Source: Dukascopy Bank SA
Novo Nordisk cut its 2025 outlook despite Q1 profit beat, citing weak U.S. prescriptions. CEO highlights 18% sales growth and wider GLP-1 treatment reach.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.